Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Dihydroergotamine mesylate
Medication labelTRUDHESA is indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use TRUDHESA is not indicated for…
Why this: Advisory · dailymed-prescription
TRUDHESA is indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use TRUDHESA is not indicated for the preventive treatment of migraine. TRUDHESA is not indicated for the management of hemiplegic or basilar migraine.
- generic_name
- dihydroergotamine mesylate
- product_names
- Dihydroergotamine mesylate
- ndc
- 77530-725, 77530-725-04, 77530-725-00, 77530-725-06
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en